poisar

Stocks · News reference

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fiscal.ai

CareDx, Inc. awarded restricted stock units (RSUs) to 21 new employees as an inducement material to their acceptance of employment.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Fiscal.ai

    CareDx, Inc. Files Form 144

    CareDx, Inc. filed a Form 144 with the SEC on November 5, 2026, as reported by StreetInsider.

  2. Zacks Investment ResearchZacks.Com

    CareDx Q3 Earnings Call Highlights Raised '26 Outlook & Testing Growth

    CareDx raised its 2026 revenue guidance to $520M-$530M and adjusted EBITDA outlook to $90M-$100M, driven by strong transplant testing demand with volumes up 21% to 50,750. The company's specialty oncology business (NavDx) contributed $12.5M in Q3 revenues with 37% year-over-year growth. Management is preparing new molecular diagnostics AlloHeme and HistoMap Kidney for 2027 commercialization while targeting higher reimbursement rates per test.